Phase 2 trial of high-dose rituximab with high-dose cytarabine mobilization therapy and high-dose thiotepa, busulfan, and cyclophosphamide autologous stem cell transplantation in patients with central nervous system involvement by non-Hodgkin lymphoma

By Chen Yi-Bin   Batchelor Tracy   Li Shuli   Hochberg Ephraim   Brezina Mark   Jones Sooae   Del Rio Candice   Curtis Morgan   Ballen Karen K.   Barnes Jeffrey   Chi Andrew S.   Dietrich Jorg   Driscoll Jessica   Gertsner Elizabeth R.   Hochberg Fred   LaCasce Ann S.   McAfee Steven L.   Spitzer Thomas R.   Nayak Lakshmi   Armand Philippe  

Cancer, Vol. 121, Iss. 2, 2015-01 ,pp. : 226-233

Blackwell Publishing

Access to resources Recommend Favorite

Medication Management of Adult Patients Admitted to Hospital with Epilepsy, Seizure or Convulsion

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 42, Iss. 4, 2012-12 ,pp. : 291-295

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacodynamic genes do not influence risk of neutropenia in cancer patients treated with moderately high-dose irinotecan

By Hoskins Janelle M   Rosner Gary L   Ratain Mark J   McLeod Howard L   Innocenti Federico  

Pharmacogenomics, Vol. 10, Iss. 7, 2009-07 ,pp. : 1139-1146

Future Medicine

Access to resources Recommend Favorite

An ex vivo Study of Foam Cell Formation and Cholesterol Clearance in Macrophages Isolated from Patients with Hypertriglyceridemia and Low High-Density Lipoprotein Cholesterol Treated with High-Dose Simvastatin

By  

Heart Drug, Vol. 1, Iss. 1, 2001-03 ,pp. : 32-34

Karger

Access to resources Recommend Favorite

High-dose IV methylprednisolone therapy effectively treated haemangioendothelioma

By  

Inpharma, Vol. 1, Iss. 1283, 2001-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite